BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3480633)

  • 1. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
    Chernoglazova EM
    Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 3. [The efficacy of preparations with antioxidant action in the combined treatment of phlegmons of the maxillofacial area].
    Ragimov ChR
    Stomatologiia (Mosk); 1992; (3-6):35-7. PubMed ID: 1307152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of netromycin in suppurative maxillofacial surgery in children].
    Roginskiĭ VV; Gerchikov LN; Raĭlian SK; Beliaeva EI; Pavelko GA
    Stomatologiia (Mosk); 1994; 73(3):68-71. PubMed ID: 7846723
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical and experimental bases for using dibasol in inflammatory diseases of the maxillofacial area].
    Alekhova TM
    Stomatologiia (Mosk); 1982; 61(1):15-7. PubMed ID: 6950550
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of nitatsid and gipozol'-N in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Tarasenko SV; Aleksashina IP; Agapov VS; Trukhina GM; Liapunov NA
    Stomatologiia (Mosk); 2000; 79(2):17-9. PubMed ID: 10812984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tactivin in the combined treatment of acute inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Arion VIa; Sysoeva OP; Krugliakova EP
    Stomatologiia (Mosk); 1996; 75(2):31-3. PubMed ID: 8754536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The optimization of the regeneration of a suppurative wound in the maxillofacial area by using lymphogenic therapy].
    Shumskiĭ AV; Pozdniĭ AIu; Morozov PV
    Voen Med Zh; 1999 May; 320(5):28-33. PubMed ID: 10401246
    [No Abstract]   [Full Text] [Related]  

  • 9. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM; Paliĭ GK; Burdeniuk IP
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of the preparation baliz-2 in inflammatory processes of the maxillofacial area].
    Bernadskaia GP; Timofeev AA; Kutsenko TA
    Stomatologiia (Mosk); 1989; 68(6):10-1. PubMed ID: 2623675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV; Tsarev VN; Dugarov BD; Lopyrev VA
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of multiple-component ointments on a hydrophilic base for treating suppurative inflammatory processes of the oral cavity].
    Kirsanov PV; Murzina OF
    Stomatologiia (Mosk); 1988; 67(6):11-2. PubMed ID: 3238707
    [No Abstract]   [Full Text] [Related]  

  • 13. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

  • 15. [The use of alginic acid-based preparations for treating suppurative wounds of the maxillofacial area and neck].
    Ushakov RV; Dugarov BD; Iakubovich VS; Komissarova AL; Shargorodskiĭ VM
    Stomatologiia (Mosk); 1991; (5):46-7. PubMed ID: 1724711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of proteolytic enzymes in the treatment of acute suppurative diseases of the maxillo-facial area].
    Protasevich AI
    Vestn Khir Im I I Grek; 1969 Mar; 102(3):83-5. PubMed ID: 5358819
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunostimulants in the combined treatment of patients with odontogenic abscesses and phlegmon].
    Biberman IaM; Shutova AP; Starodubtsev VS; Mordvinova NB; Baranova GV
    Stomatologiia (Mosk); 1985; 64(1):43-5. PubMed ID: 3857740
    [No Abstract]   [Full Text] [Related]  

  • 18. [Sialic acid content of the blood in phlegmon of the maxillofacial area].
    Karandashov VI; Petukhov EB
    Stomatologiia (Mosk); 1983; 62(1):39-41. PubMed ID: 6572434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinico-immunological parallels of nonspecific factors of body reactivity in patients with maxillofacial phlegmon].
    Bazhanov NN; Iunuskhodzhaev E; Belokrinitskiĭ DV; Smirnova VM; Kudriavitskiĭ AI
    Stomatologiia (Mosk); 1988; 67(1):32-5. PubMed ID: 3163192
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN; Ganina SS; Pashutin SB; Ragimov ChR
    Sov Med; 1991; (7):29-31. PubMed ID: 1948337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.